Sort by
Previous Page Page 1 of 11 Next Page
  1. Research

    Cost-effectiveness analysis of the diarrhea alleviation through zinc and oral rehydration therapy (DAZT) program in rural Gujarat India: an application of the net-benefit regression framework

    This study evaluates the cost-effectiveness of the DAZT program for scaling up treatment of acute child diarrhea in Gujarat India using a net-benefit regression framework.

    Samuel D. Shillcutt, Amnesty E. LeFevre, Christa L. Fischer-Walker, Sunita Taneja, Robert E. Black and Sarmila Mazumder

    Cost Effectiveness and Resource Allocation 2017 15:9

    Published on: 8 June 2017

  2. Methodology

    Estimating outcomes and cost effectiveness using a single-arm clinical trial: ofatumumab for double-refractory chronic lymphocytic leukemia

    Ofatumumab (Arzerra®, Novartis) is a treatment for chronic lymphocytic leukemia refractory to fludarabine and alemtuzumab [double refractory (DR-CLL)]. Ofatumumab was licensed on the basis of an uncontrolled Phas...

    Anthony J. Hatswell, Gwilym J. Thompson, Penny A. Maroudas, Oleg Sofrygin and Thomas E. Delea

    Cost Effectiveness and Resource Allocation 2017 15:8

    Published on: 26 May 2017

  3. Review

    Economic evaluations of vaccines in Canada: a scoping review

    This study aims to summarise and describe the evolution of published economic evaluations of vaccines in Canada, thereby outlining the current state of this expanding and meaningful research.

    Ellen R. S. Rafferty, Heather L. Gagnon, Marwa Farag and Cheryl L. Waldner

    Cost Effectiveness and Resource Allocation 2017 15:7

    Published on: 5 May 2017

  4. Research

    Efficiency and productivity assessment of public hospitals in Greece during the crisis period 2009–2012

    This study is an initial effort to examine the dynamics of efficiency and productivity in Greek public hospitals during the first phase of the crisis 2009–2012. Data were collected by the Ministry of Health af...

    P. Xenos, J. Yfantopoulos, M. Nektarios, N. Polyzos, P. Tinios and A. Constantopoulos

    Cost Effectiveness and Resource Allocation 2017 15:6

    Published on: 26 April 2017

  5. Methodology

    Defining a staged-based process for economic and financial evaluations of mHealth programs

    Mobile and wireless technology for health (mHealth) has the potential to improve health outcomes by addressing critical health systems constraints that impede coverage, utilization, and effectiveness of health...

    Amnesty E. LeFevre, Samuel D. Shillcutt, Sean Broomhead, Alain B. Labrique and Tom Jones

    Cost Effectiveness and Resource Allocation 2017 15:5

    Published on: 17 April 2017

  6. Research

    Cost-effectiveness analysis of the national decentralization policy of antiretroviral treatment programme in Zambia

    In resource-limited settings with a high prevalence of human immunodeficiency virus (HIV) infection such as Zambia, decentralization of HIV/acquired immunodeficiency syndrome (HIV/AIDS) treatment and care with...

    Shinsuke Miyano, Gardner Syakantu, Kenichi Komada, Hiroyoshi Endo and Tomohiko Sugishita

    Cost Effectiveness and Resource Allocation 2017 15:4

    Published on: 12 April 2017

  7. Research

    Economic evaluation of participatory learning and action with women’s groups facilitated by Accredited Social Health Activists to improve birth outcomes in rural eastern India

    Neonatal mortality remains unacceptably high in many low and middle-income countries, including India. A community mobilisation intervention using participatory learning and action with women’s groups facilita...

    Rajesh Kumar Sinha, Hassan Haghparast-Bidgoli, Prasanta Kishore Tripathy, Nirmala Nair, Rajkumar Gope, Shibanand Rath and Audrey Prost

    Cost Effectiveness and Resource Allocation 2017 15:2

    Published on: 21 March 2017

  8. Review

    International lessons in new methods for grading and integrating cost effectiveness evidence into clinical practice guidelines

    Economic evidence is influential in health technology assessment world-wide. Clinical Practice Guidelines (CPG) can enable economists to include economic information on health care provision. Application of ec...

    Kathryn M. Antioch, Michael F. Drummond, Louis W. Niessen and Hindrik Vondeling

    Cost Effectiveness and Resource Allocation 2017 15:1

    Published on: 10 February 2017

  9. Research

    Optimizing treatment for the prevention of pre-eclampsia/eclampsia in Nepal: is calcium supplementation during pregnancy cost-effective?

    In Nepal, pre-eclampsia/eclampsia (PE/E) causes an estimated 21% of maternal deaths annually and contributes to adverse neonatal birth outcomes. Calcium supplementation has been shown to reduce the risk of PE/...

    Isabelle Feldhaus, Amnesty E. LeFevre, Chandra Rai, Jona Bhattarai, Deirdre Russo, Barbara Rawlins, Pushpa Chaudhary and Kusum Thapa

    Cost Effectiveness and Resource Allocation 2016 14:13

    Published on: 28 December 2016

  10. Review

    Advancing aged care: a systematic review of economic evaluations of workforce structures and care processes in a residential care setting

    Long-term care for older people is provided in both residential and non-residential settings, with residential settings tending to cater for individuals with higher care needs. Evidence relating to the costs a...

    Tiffany Easton, Rachel Milte, Maria Crotty and Julie Ratcliffe

    Cost Effectiveness and Resource Allocation 2016 14:12

    Published on: 12 December 2016

  11. Research

    What are we paying for? A cost-effectiveness analysis of patented denosumab and generic alendronate for postmenopausal osteoporotic women in Australia

    Zoledronic acid and denosumab were funded by the Australian government for the management of osteoporosis at an equivalent price to alendronate. The price of alendronate has declined by around 65 %, but the pr...

    Jonathan Karnon, Ainul Shakirah Shafie, Nneka Orji and Sofoora Kawsar Usman

    Cost Effectiveness and Resource Allocation 2016 14:11

    Published on: 13 October 2016

  12. Research

    Prevention and treatment of cardiovascular disease in Ethiopia: a cost-effectiveness analysis

    The coverage of prevention and treatment strategies for ischemic heart disease and stroke is very low in Ethiopia. In view of Ethiopia’s meager healthcare budget, it is important to identify the most cost-effe...

    Mieraf Taddesse Tolla, Ole Frithjof Norheim, Solomon Tessema Memirie, Senbeta Guteta Abdisa, Awel Ababulgu, Degu Jerene, Melanie Bertram, Kirsten Strand, Stéphane Verguet and Kjell Arne Johansson

    Cost Effectiveness and Resource Allocation 2016 14:10

    Published on: 12 August 2016

  13. Research

    Mothers’ willingness to pay for HPV vaccines in Anambra state, Nigeria: a cross sectional contingent valuation study

    Human papilloma virus (HPV) vaccination in Nigeria will require substantial financing due to high cost of HPV vaccine and inexistence of structures to support adolescent vaccination. Alternative sources are ne...

    Ifeoma Blessing Umeh, Sunday Odunke Nduka and Obinna Ikechukwu Ekwunife

    Cost Effectiveness and Resource Allocation 2016 14:8

    Published on: 6 June 2016

  14. Research

    Cost-utility of ranibizumab versus aflibercept for treating Greek patients with visual impairment due to diabetic macular edema

    To conduct a cost-utility analysis of ranibizumab versus aflibercept for the treatment of patients with visual impairment due to diabetic macular edema (DME) in the Greek setting.

    Georgia Kourlaba, John Relakis, Ronan Mahon, Maria Kalogeropoulou, Georgia Pantelopoulou, Olga Kousidou and Nikos Maniadakis

    Cost Effectiveness and Resource Allocation 2016 14:7

    Published on: 14 April 2016

  15. Research

    The value of using a brain laser interstitial thermal therapy (LITT) system in patients presenting with high grade gliomas where maximal safe resection may not be feasible

    The objective of this analysis was to determine the value (incremental cost/increment benefit) of a brain LITT system versus employing current surgical options recommended by NCCN guidelines, specifically open...

    Jeffrey D. Voigt and Gene Barnett

    Cost Effectiveness and Resource Allocation 2016 14:6

    Published on: 21 March 2016

  16. Reviewer acknowledgement

    Annual acknowledgement of manuscript reviewers

    The editors of Cost Effectiveness and Resource Allocation would like to thank all our reviewers who have contributed to the journal in volume 13 (2015).

    Joan Rovira

    Cost Effectiveness and Resource Allocation 2016 14:5

    Published on: 11 March 2016

  17. Research

    The economic burden of childhood pneumococcal diseases in The Gambia

    Streptococcus pneumoniae is a common cause of child death. However, the economic burden of pneumococcal disease in low-income countries is poorly described. We aimed to estimate from a...

    Effua Usuf, Grant Mackenzie, Sana Sambou, Deborah Atherly and Chutima Suraratdecha

    Cost Effectiveness and Resource Allocation 2016 14:4

    Published on: 17 February 2016

  18. Review

    Economic evaluations of interventions to reduce neonatal morbidity and mortality: a review of the evidence in LMICs and its implications for South Africa

    Newborn mortality, comprising a third of all under-5 deaths, has hardly changed in low and middle income countries (LMICs) including South Africa over the past decade. To attain the MDG 4 target, greater empha...

    Mandy Maredza, Lumbwe Chola and Karen Hofman

    Cost Effectiveness and Resource Allocation 2016 14:2

    Published on: 26 January 2016

  19. Research

    Efficiency of private and public primary health facilities accredited by the National Health Insurance Authority in Ghana

    Despite improvements in a number of health outcome indicators partly due to the National Health Insurance Scheme (NHIS), Ghana is unlikely to attain all its health-related millennium development goals before t...

    Robert Kaba Alhassan, Edward Nketiah-Amponsah, James Akazili, Nicole Spieker, Daniel Kojo Arhinful and Tobias F Rinke de Wit

    Cost Effectiveness and Resource Allocation 2015 13:23

    Published on: 26 December 2015

  20. Research

    Cost-effectiveness of umeclidinium/vilanterol combination therapy compared to tiotropium monotherapy among symptomatic patients with chronic obstructive pulmonary disease in the UK

    The cost-effectiveness of umeclidinium bromide-vilanterol (UMEC/VI) versus tiotropium monotherapy in the UK was assessed using a UMEC/VI treatment-specific economic model based on a chronic obstructive pulmona...

    Yogesh Suresh Punekar, Graeme Roberts, Afisi Ismaila and Martin O’Leary

    Cost Effectiveness and Resource Allocation 2015 13:22

    Published on: 12 December 2015

  21. Research

    Cost-effectiveness analysis of oral anti-viral drugs used for treatment of chronic hepatitis B in Turkey

    All international guidelines suggested that Tenofovir and Entecavir are the primary drugs at the first line therapy for the treatment of chronic hepatitis B (CHB). However, in Turkey these medications reimburs...

    Guvenc Kockaya, Akin Kose, Fatma Betul Yenilmez, Oktay Ozdemir and Ece Kucuksayrac

    Cost Effectiveness and Resource Allocation 2015 13:21

    Published on: 10 December 2015

Previous Page Page 1 of 11 Next Page